Fractalkine及其受体CX3CR1与冠心病
被引量:1
摘要
趋化因子fractalkine被炎症内皮细胞表达,与受体CX3CR1结合通过黏附和趋化作用、参与免疫及细胞间信息转导以及CX3CR1基因的多态性等多种途径影响动脉粥样硬化的发生和发展。通过对fractalkine蛋白及其受体CX3CR1 V249/Ⅰ249基因水平的检测以及其作用机制的干预,可能成为冠状动脉粥样硬化性心脏病早期诊断和防治的新途径。
出处
《国外医学(老年医学分册)》
2003年第5期195-198,共4页
Foreign Medical Sciences(Geriatrics)
参考文献18
-
1cDermott DH, Halcox JP, Schenke WH et al. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.Circ Res, 2001; 89 (5): 401~407.
-
2Bazan JF, Bacon KB, Hardiman G et al. A new class of membrane- bound chemokine with a CX3C motif. Nature,1997; 385 (6617): 640~644.
-
3Nomiyama H, Imai T, Kusuda J et al. Human chemokines fractalkine ( SCYD1 ), MDC ( SCYA22 ) and TARC(SCYA17) are clustered on chromosome 16q 13. Cytogenet Cell Genet, 1998; 81 (1): 10~11.
-
4Imai T, Hieshima K, Haskell C et al. Identification and molecular characterization of fractalkine receptor CX3CR1,which mediates both leukocyte migration and adhesion. Cell,1997; 91 (4)- 521~530.
-
5Combadiere C, Csalzwedet K, Smith ED et al. Idenification of CX3CR1, A chemotatic receptor, for the human CX3C chemokine fractalkine and fusion coreceptc, for HIV- 1. J Biol Chem, 1998; 273 (37): 23799~23804.
-
6Balggiolinl M, Dewald B, Morse B. Human chemokines: An update Annu Rev Immunol, 1997; 15. 675~705.
-
7Greaves DR, Hakkinen T, Lugs AD et M. Linked chromosome 16q13 chemokines, macrophage-derived chemokine,fractalkine, and thymus- and activation- regulated chemokine, are expressed in human atherosclerotic lesios.Arterioscler Thromb Vasc Biol, 2001; 21 (6): 923~92.
-
8Mizoue LS, Bazan JF, Johnson EC et al. Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N- terminal fragment of CX3CR1.Biochemistry, 1999; 38 (5): 1402~1414 J Exp Med,1998; 188 (8): 1413~1419.
-
9Haskell CA, Cleary MD, Charo IF. Moleular uncoupling of fractalkine- mediated cell adhesion and signal transduction;rapid flow arrest of CX3CR1 - expressing cells is ndependent of G- protein activation. J Biol Chem, 1999; 274 (15):10053~10058.
-
10Yoneda O, Imai T, Goda S. Fractalkine-mediated endothelial cell injury by Nk cells. J Immunol, 2000; 164 (8):4055~4062.
同被引文献11
-
1邓开伯,邓开叔,夏宏器.应重视冠心病炎症机制的研究[J].中国心血管杂志,2005,10(5):321-321. 被引量:3
-
2Wong B W, Wong D, McManus B M. Characterization of fractalkine ( CX3CL1 ) and CX3CR1 in human coronary arteries with native atheroscleros, diabetes mellitus, and transplant vascular disease [ J ]. Cardiovasc Pathol, 2002, 11(6): 332-338.
-
3Nishimura M, Umehara H, Nakayama T, et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin +/granzyme B + cytotoxic effector lymphocytes that are defined by CX3CR1 expression[J]. J Immunol, 2002, 168( 12): 6173-6180.
-
4Kerfoot S M, Lord S E, Bell R B, et al. Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions; a mechanism for selective monocyte recruitment [J]. Eur J Immuol, 2003,33(3) : 729-739.
-
5Gensini G G. A more meaningful scoring system for determining the severity of coronary heart disease [ J ]. Am J Cardiol, 1983, 51 ( 3 ) : 606.
-
6Freudlich B, Avdalovic N. Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes[ J]. J Immumol Methods, 1983, 62(1) : 31-37.
-
7McDermott D H, Halcox J P, Schenke W H, et al. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis [ J]. Circ Res, 2001,89(5) : 401-407.
-
8Umehara H, Bloom E T, Okazaki T, et al. Fractalkine in vascular biology: from basic research to clinical disease[ J ]. Arterioscler Thromb Vasc Biol, 2004, 24(1): 34-40.
-
9Gugl A, Renner W, Seinost G, et al. Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease[J]. Atherosclerosis, 2003, 166(2): 339-343.
-
10Barlic J, Zhang Y, Foley J F, et al. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway [ J ]. Circulation, 2006, 114(8): 807-819.
-
1董传仁,苏君梅.细胞凋亡信号转导与心血管疾病[J].微循环学杂志,2000,10(4):6-8. 被引量:6
-
2黄贤珍.血浆网膜素-1与2型糖尿病肾病的关系[J].空军医学杂志,2014,30(4):212-214. 被引量:6
-
3无,黄玮(摄影).糖尿病体检项目[J].医药世界,2007(10):64-69.
-
4李润泽.药物性肝损害的早期诊断和防治[J].中国药学杂志,1992,27(5):295-297. 被引量:2
-
5彭立人.糖尿病肾病[J].中国全科医学,2006,9(2):91-93. 被引量:24
-
6任宙辉,秦金陵.老年人肺结核320例临床分析[J].临床肺科杂志,2009,14(2):150-151. 被引量:10
-
7彭婕,左长京.肝纤维化动物模型及其影像检查进展[J].中华临床医师杂志(电子版),2012,6(11):141-144. 被引量:4
-
8乐进.超声诊断脂肪肝的分析和意义[J].中国社区医师(医学专业),2009,11(20):195-196.
-
9陈兰英,李红,卢薇娜.胱抑素C与2型糖尿病视网膜病变的相关性研究[J].中华内分泌代谢杂志,2013,29(5):377-379. 被引量:17
-
10肖波.重视糖尿病周围神经病的早期诊断和防治[J].中华神经科杂志,2008,41(10):649-652. 被引量:11